Newsroom

News

Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in around 30 percent of treated patients. A research team at the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) has now been able to produce an inactivated, harmless form of colistin that is only activated in the body with the help of chemical switches. In this so-called click-to-release technique, the chemical switches are specifically bound to the disease-causing bacteria. The administered masked colistin is therefore activated specifically at the site of action. The researchers hope that this could reduce side effects. The study was published in the journal Angewandte Chemie.

21.10.2024

HZI Campus

News

According to the WHO, antimicrobial resistance (AMR) is one of the ten greatest threats to global health. In the EU alone, around 35,000 people die every year from antibiotic-resistant infections. The WHO estimates that 1.27 million deaths worldwide in 2019 were directly attributable to drug-resistant infections.

18.10.2024

HZI Campus

Schematic representation of metagenome data

News

Microorganisms do not just colonize the body of mammals during infections. Billions of microbes can be found on and in healthy humans and animals at any given time, communicating with each other via chemical signals and thus influencing their health. In two studies, researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University and Saarland University Hospital have now conducted a detailed study of the microbiome, i.e. the totality of all microorganisms, in humans and zoo animals. The aim was to identify starting points for strategies for the treatment and diagnosis of diseases. The researchers published their results in two articles in the journal Nature Communications. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

17.10.2024

HIPS

Sébastien Calvignac-Spencer with Julia Demann

News

To prepare us for future pandemics, researchers at the Helmholtz Institute for One Health (HIOH) not only look at the pathogens, but also at how changes in the environment and nature - including those caused by us - influence how pathogens have developed in the past. Prof. Sébastien Calvignac-Spencer heads the research group "Evolution of Pathogens" at HIOH and uses genetic changes to retrospectively analyse what could have caused this change. In the HZI podcast InFact, he explains how this allows valuable conclusions to be drawn about how today's pathogens could develop.

14.10.2024

HIOH

News

The intestinal microbiome is currently the subject of intensive research, as it is of great importance for human health. Intestinal bacteria play an essential role in the defense against dangerous pathogens, which is one of the reasons why the majority of them are among the good guys. On the other hand, some of our lodgers are more prevalent in specific diseases - for whatever reason. This also applies to the widespread but little-researched bacterium Segatella copri. The research group led by Prof Till Strowig at the Helmholtz Centre for Infection Research (HZI) wanted to determine what makes this bacterium tick. How does it adapt to its environment? And what signals does it react to?

08.10.2024

HZI Campus

HIRI

Ankündigung des Helmholtz Health Summits am 8. Oktober in Berlin

News

What opportunities lie ahead for the future of medical research and healthcare systems? Researchers from the Helmholtz Association exchange ideas with decision-makers from science, politics, patient organizations, biotech, and the pharmaceutical industry at the Helmholtz Health Summit. The conference focuses on scientific developments that will have a long-term impact on medicine and healthcare. Topics include digital health, artificial intelligence, personalized therapy, prevention, pandemic resilience, and research transfer.

08.10.2024

HZI Campus

HIOH

Back to the first page
...
16
17
18
19
...
147

HZI in the media

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025

Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025

AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025

Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025

Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025

Apotheken Umschau

... am 1. Oktober 2025. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

07.10.2025

juraforum.de

... „Epidemiologie und Ökologie antimikrobieller Resistenz“ am HZI-Standort Helmholtz-Institut für One Health (HIOH), am Projekt ...

06.10.2025

Bochumer-Zeitung

” says Mark Brönstrup, a professor at both the Helmholtz Center for Infection Research and Leibniz University Hannover, who wasn’t involved

04.10.2025

MIT CSAIL

... Hannover (MHH) und Klinischer Direktor des Helmholtz-Zentrums für Infektionsforschung (HZI). Auch an der Gründung des ...

03.10.2025

Deutsches Ärzteblatt

... des Sensormoleküls

Prof. Carlos A. Guzmán (Helmholtz-Zentrum für Infektionsforschung, Braunschweig) mit den Teams um Dr. ...

02.10.2025

Medizin Aspekte

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025

Die heutigen Nachrichten

” (Vico) within the Human program at the Helmholtz Centre for Infection Research (HZI).the‌ Vico group continues to investigate resilience

25.09.2025

World Today News

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.